Research programme: polysaccharide conjugate vaccines - AstraZeneca/Omniose
Latest Information Update: 19 Jan 2024
At a glance
- Originator AstraZeneca
- Class Bacterial vaccines; Conjugate vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Bacterial infections